Regen BioPharma (RGBP) Invested Capital (2016 - 2025)
Historic Invested Capital for Regen BioPharma (RGBP) over the last 12 years, with Q4 2025 value amounting to -$6.6 million.
- Regen BioPharma's Invested Capital fell 1574.13% to -$6.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$6.6 million, marking a year-over-year decrease of 1574.13%. This contributed to the annual value of -$6.3 million for FY2025, which is 2038.98% down from last year.
- Latest data reveals that Regen BioPharma reported Invested Capital of -$6.6 million as of Q4 2025, which was down 1574.13% from -$6.3 million recorded in Q3 2025.
- In the past 5 years, Regen BioPharma's Invested Capital registered a high of -$4.4 million during Q2 2024, and its lowest value of -$76.7 million during Q1 2022.
- Its 5-year average for Invested Capital is -$10.0 million, with a median of -$5.7 million in 2024.
- As far as peak fluctuations go, Regen BioPharma's Invested Capital crashed by 143235.24% in 2022, and later soared by 9370.8% in 2023.
- Regen BioPharma's Invested Capital (Quarter) stood at -$8.3 million in 2021, then surged by 41.19% to -$4.9 million in 2022, then rose by 9.06% to -$4.4 million in 2023, then decreased by 27.86% to -$5.7 million in 2024, then dropped by 15.74% to -$6.6 million in 2025.
- Its Invested Capital stands at -$6.6 million for Q4 2025, versus -$6.3 million for Q3 2025 and -$5.8 million for Q2 2025.